Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.

PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.

2.

Extensively drug-resistant tuberculosis: current challenges and threats.

Jain A, Mondal R.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):145-50. doi: 10.1111/j.1574-695X.2008.00400.x. Epub 2008 May 8. Review.

3.

Extensively drug-resistant tuberculosis: new strains, new challenges.

Banerjee R, Schecter GF, Flood J, Porco TC.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Review.

PMID:
18847407
4.

Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.

Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C.

Clin Chest Med. 2009 Dec;30(4):637-65, vii. doi: 10.1016/j.ccm.2009.08.015. Review.

PMID:
19925959
5.

Management of multidrug resistant tuberculosis.

Daley CL, Caminero JA.

Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4. Review.

PMID:
23460005
6.

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.

Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, Steingart KR, Dheda K.

Cochrane Database Syst Rev. 2014 Oct 29;(10):CD010705. doi: 10.1002/14651858.CD010705.pub2. Review.

7.

Extensively drug-resistant tuberculosis.

LoBue P.

Curr Opin Infect Dis. 2009 Apr;22(2):167-73. Review.

PMID:
19283912
8.

Extensively drug-resistant tuberculosis: epidemiology and management challenges.

Dheda K, Warren RM, Zumla A, Grobusch MP.

Infect Dis Clin North Am. 2010 Sep;24(3):705-25. doi: 10.1016/j.idc.2010.05.001. Review.

PMID:
20674800
9.

Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.

Chang KC, Yew WW.

Respirology. 2013 Jan;18(1):8-21. doi: 10.1111/j.1440-1843.2012.02257.x. Review.

10.

Extensively drug-resistant tuberculosis: a case report and literature review.

Araújo-Filho JA, Vasconcelos-Jr AC, Sousa EM, Silveira Cd, Ribeiro E, Kipnis A, Junqueira-Kipnis AP.

Braz J Infect Dis. 2008 Oct;12(5):447-52. Review.

11.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
12.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
13.

Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis.

Ahmad S, Mokaddas E.

J Infect Public Health. 2014 Mar-Apr;7(2):75-91. doi: 10.1016/j.jiph.2013.09.001. Epub 2013 Nov 9. Review.

14.

Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.

Schaaf HS, Moll AP, Dheda K.

Clin Chest Med. 2009 Dec;30(4):667-83, vii-viii. doi: 10.1016/j.ccm.2009.08.019. Review.

PMID:
19925960
15.

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.

Caminero JA, Sotgiu G, Zumla A, Migliori GB.

Lancet Infect Dis. 2010 Sep;10(9):621-9. doi: 10.1016/S1473-3099(10)70139-0. Review.

PMID:
20797644
16.

[Management of multidrug-resistant tuberculosis].

Tritar F, Daghfous H, Ben Saad S, Slim-Saidi L.

Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. doi: 10.1016/j.pneumo.2014.05.001. Epub 2014 Aug 19. Review. French.

PMID:
25153927
17.

Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.

Mani V, Wang S, Inci F, De Libero G, Singhal A, Demirci U.

Adv Drug Deliv Rev. 2014 Nov 30;78:105-17. doi: 10.1016/j.addr.2014.05.015. Epub 2014 Jun 2. Review.

18.

Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.

Zignol M, Dara M, Dean AS, Falzon D, Dadu A, Kremer K, Hoffmann H, Hoffner S, Floyd K.

Drug Resist Updat. 2013 Dec;16(6):108-15. doi: 10.1016/j.drup.2014.02.003. Epub 2014 Feb 28. Review.

20.

Extensively drug-resistant tuberculosis.

Jassal M, Bishai WR.

Lancet Infect Dis. 2009 Jan;9(1):19-30. doi: 10.1016/S1473-3099(08)70260-3. Epub 2008 Nov 5. Review.

PMID:
18990610

Supplemental Content

Support Center